Episurf Medical AB (publ) publishes prospectus; Episurf’s former CEO’s incentive programmes terminated
The prospectus regarding the rights issue in Episurf Medical AB (publ) (“Episurf” or the “Company”) has been approved and registered by the Swedish Financial Supervisory Authority and is now available on the Company’s website (www.episurf.com). On 18 January 2017, the Board of Directors of Episurf resolved on an up to approximately SEK 120 million new issue of A and B shares with preferential rights for shareholders, subject to subsequent approval of an extraordinary general meeting. The extraordinary general meeting held on 20 February 2017 resolved to approve the resolution of the